In the light of above conclusions, Hp-activated fibroblasts, especially by highly procarcinogenic Hp strains, seem to constitute the target for anti-cancer therapies and importantly for the pharmacotherapy diminishing fibroblast activation particularly at the early stages of Hp infection. This evidence concerns the gene HP and cancer.